Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Completes Pilot Study of Gentana s Gene-mapping Tech

NEW YORK, Nov. 29 (GenomeWeb News) - Gentana said today that Monsanto has completed a pilot study of its gene-mapping technology.

 

In the study, Monsanto's seed business evaluated Gentana's technology for gene-expression profiling. Gentana said that Monsanto delivered "a positive report."

 

Thorsten Storck, COO at Gentana, told GenomeWeb News that Monsanto is currently "working on the results of the study," and that no additional agreement for his company's technology has been signed. He declined to comment further.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.